<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">arthyper</journal-id><journal-title-group><journal-title xml:lang="ru">Артериальная гипертензия</journal-title><trans-title-group xml:lang="en"><trans-title>"Arterial’naya Gipertenziya" ("Arterial Hypertension")</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-419X</issn><issn pub-type="epub">2411-8524</issn><publisher><publisher-name>Antihypertensive League</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/1607-419X-2020-26-6-699-707</article-id><article-id custom-type="elpub" pub-id-type="custom">arthyper-1914</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Особенности реакции гемодинамики на ортостаз при использовании комбинации ингибитора ангиотензинпревращающего фермента и диуретика у мужчин с артериальной гипертензией и хроническими заболеваниями вен</article-title><trans-title-group xml:lang="en"><trans-title>Hemodynamic reaction to orthostasis in hypertensive men with chronic venous diseases taking a combination of an angiotensin-converting enzyme inhibitor and diuretic</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1635-7149</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Летягина</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Letyagina</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Летягина Светлана Витальевна — врач ультразвуковой диагностики</p><p>Пермь</p></bio><bio xml:lang="en"><p>Svetlana V. Letyagina, MD, Specialist in Ultrasound Diagnostics </p><p>Perm</p></bio><email xlink:type="simple">Sveeet.L@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9283-8094</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Баев</surname><given-names>В. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Baev</surname><given-names>V. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Баев Валерий Михайлович — доктор медицинских наук, профессор кафедры анестезиологии, реаниматологии и скорой медицинской помощи </p><p>ул. Петропавловская, д.26, Пермь, 614990</p><p>Тел./факс: 8(342)249–91–14</p></bio><bio xml:lang="en"><p>Valery M. Baev, MD, PhD, DSc, Professor, Department of Anesthesiology, Intensive Care and Emergency Medicine </p><p>26 Petropavlovskaya street, Perm, 614990 </p><p>Phone/fax: 8(342)249–91–14 </p></bio><email xlink:type="simple">vmbaev@hotmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9935-0040</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Агафонова</surname><given-names>Т. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Agafonova</surname><given-names>T. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Агафонова Татьяна Юрьевна —кандидат медицинских наук, доцент кафедры пропедевтики внутренних болезней</p><p>Пермь</p></bio><bio xml:lang="en"><p>Tatyana Yu. Agafonova, MD, PhD, Associate Professor, Department of Propaedeutics of Internal Medicine </p><p>Perm</p></bio><email xlink:type="simple">agaf74@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное казенное учреждение здравоохранения «Медико-санитарная часть Министерства внутренних дел Российской Федерации по Пермскому краю»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Hospital of the Police of Russia on the Perm Edge</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Пермский государственный медицинский университет имени академика Е.А. Вагнера» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>E.A. Vagner Perm State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>26</day><month>11</month><year>2020</year></pub-date><volume>26</volume><issue>6</issue><fpage>699</fpage><lpage>707</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Летягина С.В., Баев В.М., Агафонова Т.Ю., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Летягина С.В., Баев В.М., Агафонова Т.Ю.</copyright-holder><copyright-holder xml:lang="en">Letyagina S.V., Baev V.M., Agafonova T.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://htn.almazovcentre.ru/jour/article/view/1914">https://htn.almazovcentre.ru/jour/article/view/1914</self-uri><abstract><p>Цель исследования — изучение особенностей реакции гемодинамики на ортостаз при использовании комбинации ингибитора ангиотензинпревращающего фермента (ИАПФ) и диуретика у мужчин с артериальной гипертензией (АГ) и хроническими заболеваниями вен (ХЗВ).  Материалы и методы. У 44 мужчин 30–50 лет с неконтролируемой АГ на фоне антигипертензивной терапии (АГТ) выполнена сравнительная оценка динамики систолического артериального давления (САД), диастолического артериального давления (ДАД), частоты сердечных сокращений, периферического венозного давления (ПВД) бедра, диаметра и площади просвета, скорости кровотока поверхностных и глубоких вен левой ноги в ответ на ортостаз. Оценивали параметры пациентов двух групп: 22 пациента с АГ без ХЗВ, 22 пациента с АГ и ХЗВ. Изучали реакцию на 3-й минуте ортостаза до и после 14-дневной АГТ в стационаре с применением ИАПФ («Периндоприл») и диуретика («Индапамид»).  Результаты. До лечения обе группы на ортостаз реагировали идентично — снижением САД, ПВД, скорости кровотока и увеличением диаметра, площади просвета всех вен. В результате лечения 40 пациентов достигли уровня САД &lt; 140 мм рт. ст. Из них пациентов без ХЗВ было 19 человек, с ХЗВ — 21 человек. После лечения большинство изучаемых параметров в изучаемых группах отреагировали на ортостаз так же, как и до лечения. Однако между группами отмечены некоторые различия. Для пациентов с АГ и ХЗВ реакция на ортостаз после лечения отличалась снижением САД, отсутствием реакции ДАД, 4-кратным падением ПДВ и регистрацией 3 случаев ортостатической гипотензии. После лечения у пациентов с ХЗВ при ортостазе САД и ДАД были значительно ниже, чем у пациентов без ХЗВ (p = 0,0014 и p = 0,0028 соответственно). Разница САД между группами после лечения составила 12 мм рт. ст. (9%), по ДАД — 6 мм рт. ст. (7%).  Заключение. После 14–15-дневного применения комбинации ИАПФ и диуретика большинство изучаемых параметров в изучаемых группах отреагировали так же, как и до лечения. Для пациентов с АГ и ХЗВ характерной особенностью реакции на ортостаз является снижение САД, отсутствие реакции ДАД, падение ПДВ в 4 раза и регистрация 3 случаев ортостатической гипотензии.</p></abstract><trans-abstract xml:lang="en"><p>Objective. To assess the hemodynamic reaction to orthostasis in hypertensive men with chronic venous diseases (CVenD) taking a combination of an angiotensin-converting enzyme inhibitor (ACE inhibitor) and a diuretic.  Design and methods. We enrolled 44 men aged 30–50 years old with uncontrolled hypertension (HTN) who were taking antihypertensive therapy (AHT). We performed a comparative assessment of the changes in systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate, femoral peripheral venous pressure (PVP), diameter and area of the lumen, blood flow velocity in the superficial and deep veins of the left lower limb in response to orthostasis. The patients were divided into two groups: 22 patients with HTN without chronic venous insufficiency, 22 patients with HTN and chronic venous disease. We studied the reaction at 3 minutes of orthostasis before and after 14 days of AHT in a hospital using ACE inhibitors (Perindopril) and a diuretic (Indapamide).  Results. Before treatment, the reaction to orthostasis was similar in both groups, we registered a decrease in SBP, PVP, blood flow velocity and an increase in diameter, lumen area of all veins. As a result of treatment, 40 patients reached a level of SBP &lt; 140 mm Hg. Of these, there were 19 patients without CVenD, and 21 patients with CVenD. After treatment, the reaction to orthostasis was similar for the most of the studied parameters. However, there were some differences between the groups. After treatment, patients with HTN and CVenD demonstrated a decrease in SBP, the absence in DBP change, a 4-fold drop in PVP, and orthostatic hypotension was registered in 3 cases. After treatment, in patients with CVenD with orthostasis, SBP and DBP were significantly lower than in patients without CVenD (p = 0,0014 and p = 0,0028, respectively). The difference in SBP between groups after treatment was 12 mm Hg (9%), according to DBP — 6 mm Hg (7%).  Conclusions. At baseline and after a 14–15-day use of the combination of ACE inhibitors and a diuretic, the reaction to orthostasis was similar for most of the studied parameters. In patients with HTN and CVenD, the main features of the reaction to orthostasis included a decrease in SBP, the absence of DBP change, a 4-fold drop in PVP, and orthostatic hypotension registered in 3 cases.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>мужчины</kwd><kwd>артериальная гипертензия</kwd><kwd>хронические заболевания вен</kwd><kwd>антигипертензивная терапия</kwd><kwd>ортостаз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>men</kwd><kwd>hypertension</kwd><kwd>chronic vein disease</kwd><kwd>antihypertensive therapy</kwd><kwd>orthostasis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Кардиология. Национальное руководство. Под. ред. Е. В. Шляхто. M.: ГЭОТАР-Медиа, 2020. 816 с. ISBN: 978–5–9704–5397–1. [Cardiology. National guideline. Ed. Shlyakhto EV. M.: GEOTAR-Media, 2020. P. 816. ISBN:978–5–9704–5397–1. In Russian].</mixed-citation><mixed-citation xml:lang="en">Cardiology. National leadership. Edit. Shlyakhto EV. M.: GEOTAR-Media. 2020. P.816. (In Russian). ISBN: 978-5-9704-5397-1.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi:10.1093/eurheartj/ehy339</mixed-citation><mixed-citation xml:lang="en">2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal. 2018;39:3021-3104. doi:10.1093/eurheartj/ehy339.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Чесникова В.А., Сафроненко А. И., Скаржинская Н. С., Сафроненко А.В., Коломацкая О.Е. Особенности артериальной гипертензии у коморбидных больных. Медицинский Вестник Юга России. 2017;8(1):32–38. doi:10.21886/2219-8075-2017-1-32-38. [Chesnikova AI, Safronenko VA, Skarzhinskaya NS, Safronenko AV, Kolomatskaya OE. Features of arterial hypertension in patients with comorbidity. Medical Herald of the South of Russia. 2017;8(1):32–38. doi:10.21886/2219-8075-2017-1-32-38. In Russian].</mixed-citation><mixed-citation xml:lang="en">Chesnikova AI, Safronenko VA, Skarzhinskaya NS, Safronenko AV, Kolomatskaya OE. Features of arterial hypertension in patients with comorbidity. Medical Herald of the South of Russia. 2017;(1):32-38. (In Russian). doi: 10.21886/2219-8075-2017-1-32-38.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Zolotukhin IA, Seliverstov EI, Shevtsov YN, Avakiants IP, Nikishkov AS, Tatarintsev AM et al. Prevalence and risk factors for chronic venous disease in the general russian population. Eur J Vasc Endovasc Surg. 2017;54(6):752–758. doi:10.1016/j.ejvs.2017.08.033</mixed-citation><mixed-citation xml:lang="en">Zolotukhin IA, Seliverstov EI, Shevtsov YN, Avakiants IP, Nikishkov AS, Tatarintsev AM et al. Prevalence and risk factors for chronic venous disease in the general russian population. European Journal of Vascular and Endovascular Surgery. 2017; 54(6):752-758. doi: 10.1016/j.ejvs.2017.08.033.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Вагапов Т. Ф., Баев В. М. Клинические особенности хронических заболеваний вен нижних конечностей у мужчин с артериальной гипертензией. Практическая медицина. 2018;16(6):201–204. doi:10.32000/2072-1757-2018-16-6-201- 204. [Vagapov TF, Baev VM. Clinical features of chronic diseases of the veins of lower extremities in men with hypertension. Pract Med. 2018;16(6):201–204. doi:10.32000/2072-1757-2018-16-6-201-204. In Russian].</mixed-citation><mixed-citation xml:lang="en">Vagapov TF, Baev VM. Clinical features of chronic diseases of the veins of lower extremities in men with hypertension. Practical Medicine. 2018;16(6):201-204. (In Russian). doi: 10.32000/2072-1757-2018-16-6-201-204.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Bevilacqua M, Vago T, Rogolino A, Conci F, Santoli E, Norbiato G. Affinity of angiotensin I-converting enzyme (ACE) inhibitors for N- and C-binding sites of human ACE is different in heart, lung, arteries, and veins. J Cardiovasc Pharmacol. 1996;28(4):494–499. doi:10.1097/00005344-199610000-00003</mixed-citation><mixed-citation xml:lang="en">Bevilacqua M, Vago T, Rogolino A, Conci F, Santoli E, Norbiato G. Affinity of angiotensin I-converting enzyme (ACE) inhibitors for N- and C-binding sites of human ACE is different in heart, lung, arteries, and veins. J Cardiovasc Pharmacol. 1996;4:494-499. doi: 10.1097/00005344-199610000-00003.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Rabe E, Pannier F. Clinical, aetiological, anatomical and pathological classification (CEAP): “gold standard” and limits. Phlebology. 2012;27(1suppl):114–118. doi:10.1258/phleb.2012.012s19</mixed-citation><mixed-citation xml:lang="en">Rabe E, Pannier F. Clinical, aetiological, anatomical and pathological classification (CEAP): «gold standard» and limits. Phlebology: The Journal of Venous Disease. 2012;27(1 suppl):114-118. doi:10.1258/phleb.2012.012s19.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Чуриков Д.А., Кириенко А. И. Ультразвуковая диагностика болезней вен. М.: Литтерра, 2016. 176 с. ISBN: 978–5– 4235–0235–5. [Churikov DA, Kirienko AI. Ultrasound diagnosis of vein diseases. М.: LitTerra. 2016. 176 p. ISBN:978-5-4235-0235-5. In Russian].</mixed-citation><mixed-citation xml:lang="en">CHurikov DA, Kirienko AI. Ultrasound diagnosis of vein diseases. М.:LitTerra. 2016. 176p. (In Russian). ISBN: 978-5-4235-0235-5.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Шумилина М. В., Махмудов Х. Х., Мукасеева А. В., Стрелкова Т. В. Способ измерения венозного давления. Патент РФ № 2480149. 2013. URL: http://www.freepatent.ru/patents/2480149. [Shumilina MV, Makhmudov KhKh, Mukaseeva AV, Strelkova TV. Patent “Method of measuring venous pressure”. 2013. № 2480149. URL: http://www.freepatent.ru/patents/2480149. In Russian].</mixed-citation><mixed-citation xml:lang="en">Shumilina M V, Makhmudov KhKh, Mukaseeva AV, Strelkova TV. Patent "Method of measuring venous pressure".2013. № 2480149. (In Russian). http://www.freepatent.ru/patents/2480149.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Epstein SE, Beiser GD, Stampfer M, Braunwald E. Role of the venous system in baroreceptor-mediated reflexes in man. J Clin Invest. 1968;47(1):139–152. doi:10.1172/JCI105704</mixed-citation><mixed-citation xml:lang="en">Epstein SE, Beiser GD, Stampfer M, Braunwald E. Role of the venous system in baroreceptor-mediated reflexes in man. Journal of Clinical Investigation. 1968;47(1):139-52. doi: 10.1172/JCI105704.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Баев В. М., Вагапов Т. Ф., Шмелева С.А. Выраженная парасимпатикотония у мужчин с артериальной гипертензией сопровождается увеличением частоты признаков хронических заболеваний вен. Российский кардиологический журнал. 2019;(1):52–55. doi:10.15829/1560-4071-2019-1-52-55. [Baev VM, Vagapov TF, Shmeleva SA. Severe parasympathicotonia in men with hypertension is accompanied by an increase in the chronic venous diseases’ signs. Russ J Cardiology. 2019;(1):52–55. doi:10.15829/1560-4071-2019-1-52–55. In Russian].</mixed-citation><mixed-citation xml:lang="en">Baev VM, Vagapov TF, Shmeleva S.A. Severe parasympathicotonia in men with hypertension is accompanied by an increase in the chronic venous diseases’ signs. Russian Journal of Cardiology. 2019;(1):52-55. (In Russian). https://doi.org/10.15829/1560-4071-2019-1-52-55.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Munari ACF, Cervera LFF. Inflammation, metalloproteinases, chronic venous disease and sulodexide. J Cardiovasc Dis Diagn. 2015;3:203. doi:10.4172/2329-9517.1000203</mixed-citation><mixed-citation xml:lang="en">Munari ACF, Cervera LFF. Inflammation, Metalloproteinases, Chronic Venous Disease and Sulodexide. J Cardiovasc Dis Diagn.2015;3:203. doi:10.4172/2329-9517.1000203.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Rabelo ER, Rohde LE, Schaan BD, Rubira MC, Ruschel KB, Plentz RDM et al. Bradykinin or acetylcholine as vasodilators to test endothelial venous function in healthy subjects. Clinics. 2008;63(5):677–682. doi:10.1590/S1807–59322008000500017</mixed-citation><mixed-citation xml:lang="en">Rabelo ER, Rohde LE, Schaan BD, Rubira MC, Ruschel KB, Plentz RDM et al. Bradykinin or acetylcholine as vasodilators to test endothelial venous function in healthy subjects. Clinics. 2008;63(5):677-82. doi:10.1590/S1807-59322008000500017.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Российские клинические рекомендации по диагностике и лечению хронических заболеваний вен. Флебология. 2018;12(3):146–240. doi:10.17116/flebo20187031146. [Diagnostics and treatment of chronic venous disease: Guidelines of Russian Phlebological Association. Flebologiya. 2018;12(3):146– 240. doi:10.17116/flebo20187031146. In Russian].</mixed-citation><mixed-citation xml:lang="en">Diagnostics and Treatment of Chronic Venous Disease: Guidelines of Russian Phlebological Association. Flebologiya. 2018;12(3):146-240. (In Russian). doi:10.17116/flebo20187031146.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Mar PL, Raj SR. Orthostatic hypotension for the cardiologist. Curr Opin Cardiol. 2018;33(1):66–72. doi:10.1097/HCO.0000000000000467</mixed-citation><mixed-citation xml:lang="en">Mar PL, Raj SR. Orthostatic hypotension for the cardiologist. Curr Opin Cardiol. 2018;33(1):66-72. doi: 10.1097/HCO.0000000000000467.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Joseph A, Wanono R, Flamant M, Vidal-Petiot E. Orthostatic hypotension: A review. Nephrol Ther. 2017;13(1):55–67. doi:10.1016/j.nephro.2017.01.003</mixed-citation><mixed-citation xml:lang="en">Joseph A, Wanono R, Flamant M, Vidal-Petiot E. Orthostatic hypotension: A review. Nephrol Ther. 2017;13(1):55-67. doi: 10.1016/j.nephro.2017.01.003.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
